Multiple abstracts accepted featuring imdusiran clinical data – highlighting progress toward a potential functional cure for chronic hepatitis B virus AB-101 clinical data abstract recognized as a ...
Viraaj is a spirited gamer, lifelong PlayStation main, huge petrolhead, but most importantly, a principled journalist. With experience at publications like FandomWire, HotCars, and DriveTribe, writing ...
Arbutus Biopharma (ABUS) is a clinical-stage biotech focused on LNP technology, with value now hinging on ongoing patent litigation against Moderna and Pfizer/BioNTech. Recent management changes and ...
Hosted on MSN
Arbutus Biopharma’s Patent Ruling in Pfizer Lawsuit
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Arbutus ...
Arbutus Biopharma (ABUS) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.11 per share a year ago.
To enquire about specific property features for 78A Arbutus Street, Canley Heights, contact the agent. What is the size of the property at 78A Arbutus Street, Canley Heights? The external land size ...
Arbutus Biopharma had made no secret of its plans to step up its work on imdusiran. Now, the company has regained the China rights to the potential functional cure for hepatitis B. China-based Qilu ...
WARMINSTER, Pa., June 25, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The end of the deal, which ...
The ideal iPhone wallpaper size varies by model, and using the wrong size can make your wallpaper appear blurry or stretched. To get the best fit, simply check your iPhone model in Settings and refer ...
New research in rats indicates that a Mediterranean plant may be an effective treatment for ulcerative colitis, a type of inflammatory bowel disease. The findings are published in the Journal of the ...
Arbutus Biopharma Corporation announced promising data from a late-breaker poster presentation at the EASL Congress 2025, revealing that its treatment combining imdusiran, a RNAi therapeutic, with VTP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback